As shown in Figure 1A–1B, the frequency of PD-1+ cells among CD4+ T cells from NSCLC patients was significantly higher than those from HD (mean frequency 13.3%±1.1% vs. 8.8%±0.7%, P=0.0045). This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.